Skip to main content

Faysal Sohail, J. Craig Venter, Tony White


CMEA Ventures of San Francisco has named Faysal Sohail as a venture partner. Prior to joining CMEA, Sohail was CEO of Cadabra Design Automation and managed its acquisition by Numerical Technologies, where he served as senior vice president of worldwide field operations.


J. Craig Venter has stepped down as president of Celera Genomics. Venter led the company through its much-publicized sequencing of the human genome, but is leaving the post so that a replacement can lead Celera further “downstream” into pharmaceutical development. Venter, who helped found The Institute for Genomic Research (TIGR), plans to spend more time working as chairman of the organization. Applera CEO Tony White will serve as interim president of Celera until a replacement for Venter can be found.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.